Navigation Links
Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
Date:6/14/2013

HUNTINGTON BEACH, Calif., June 14, 2013 /PRNewswire/ -- The Independent Pharmacy Cooperative (IPC) and Absorption Pharmaceuticals (AP) have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States.

Promescent is fast becoming first-line therapy for premature ejaculation by numerous urologists and Large Urology Groups Practice Association (LUGPA) members across the U.S., replacing off-label medications which have known side effects. Promescent is available over-the-counter by way of FDA monograph 21 CFR 348.10 and has minimal risk of systemic side effects. The effectiveness, ease-of-use, safety, and low cost per dose of the medication are key reasons for its rise in popularity among physicians.

"Urologists want their patients to have convenient and private locations for obtaining Promescent after their office visit," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "The relationship with IPC now gives patients in virtually every location in the country the fast and confidential access to what has become a mainstream medication for PE."

Many independent pharmacies provide compounding services such as Trimix for erectile dysfunction.  Some urologists who prescribe Trimix and other injection therapies for ED are recommending Promescent to these patients in order to achieve a better overall sexual experience.

"We have witnessed a steady growth in product demand since our first member pharmacy started  carrying Promescent," says Dean Slaugenhoup, director of contracts and purchasing at IPC . "Our mission at IPC is to provide our members cost-effective and convenient access to products that have passed a threshold of acceptance by physicians and Promescent is now clearly in this categor
'/>"/>

SOURCE Absorption Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
2. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
3. Managed Health Care Associates, Inc. (MHA) Released Results of Sixth Annual Independent Long Term Care Member Study with Expanded Specialty Pharmacy Findings
4. Agnitio Launches Rainmaker One to Remove the Complexity of Managing Independent Apps
5. Independent Drugstore Lobby Wants Sweeping Antitrust Exemptions to Charge Higher Prescription Drug Prices
6. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
7. China Botanic Appoints Jack Zhao as Independent Director
8. PQ Bypass Graduates from the Fogarty Institute for Innovation, Establishes Independent Operations
9. H. D. Smith Supports Local Hospitals, Nursing Homes, Clinics And Independent Retail Pharmacies Throughout Hurricane Sandy
10. Registry Data Shows 90% Of Patients Independent, Free Of Significant Disabilities After Treatment With Codman System For Wide-necked Aneurysms
11. 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... -- Levi & Korsinsky announces that a class action ... Court for the District of Nevada ... Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities between ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt . ... the Company violated federal securities laws by issuing false ...
(Date:8/28/2014)... 2014 According to a new ... (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) - ... 2014 - 2020" the global radiofrequency identification (RFID) market ... is expected to grow at a CAGR of 13.9% ... of USD 5.3 billion in 2020. Browse ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Multiforme Therapeutics in Asia-Pacific Markets to ... High Unmet Need in Newly Diagnosed ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9
... HERZELIYA, Israel, September 30 ... in an investment round led by 7 Health,Ventures. ... in the round as well. , ... optical guidance systems used,in Computer Tomography (CT), fluoroscopy ...
... Ill., Sept. 30 Life Spine announced today that ... 510(k) marketing approval to the SENTINEL Occipito-Cervico-Thoracic (OCT) System. ... and promotes fusion from the occiput to thoracic spine, ... procedures. Polyaxial screws are available in multiple diameters and ...
Cached Medicine Technology:
(Date:8/28/2014)... 29, 2014 AltMed , ... industry precision to the development and production of ... its primary location in Sarasota County. , ... a total commitment to attracting new industry and ... says David Wright, President and CEO of AltMed. ...
(Date:8/28/2014)... When David Gergen, President of Pro Player ... was asked to publicly support Mr. Brnovich in his ... seat in the State of Arizona, Mr. Gergen could ... Hall of Fame wide receiver Roy Green in addition ... Green, Kennard and Walczak are members of Pro Player ...
(Date:8/28/2014)... New Energy Works Timberframe plans for a ... country to Log & Timber Home Shows starting in ... Energy Works team will invite the shows’ attendees into ... expertise, project images, and their new 2015 project calendar. ... Mid-West Representative, will present “A fun-fill odyssey: Realizing your ...
(Date:8/28/2014)... 42-year-old investment banker arrives at the emergency department ... He drinks alcohol every dayoften at business lunches, ... health, he decided to quit drinking and had ... emergency. , It,s a common scenario in emergency ... alcohol consumption and develops withdrawal. , Withdrawal is ...
(Date:8/28/2014)... 28, 2014 On August 21, the ... its 2013 Annual Report, featuring the organization’s audited financial ... , According to the report, in 2013, the ... programs versus 14 cents on fundraising and administration. ... a minimum,” wrote the Foundation’s chief executive officer, Melinda ...
Breaking Medicine News(10 mins):Health News:Sarasota County Approves Zoning for Leading Medical Cannabis Firm AltMed 2Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 2Health News:New Energy Works Timberframers Prepares to Exhibit Timber Framing at Autumn Trade Shows 3Health News:Real tremors, or drug-seeking patient? New app can tell 2Health News:Real tremors, or drug-seeking patient? New app can tell 3Health News:Mesothelioma Applied Research Foundation’s Annual Report 2013 Release 2
... 2008) -- Pancreatic cancer is one of the ... in a major step forward, researchers at NewYork-Presbyterian ... radiation therapy prior to surgery nearly doubles survival ... "Patients who received pre-surgical (neoadjuvant) radiation had almost ...
... unmatched in its ability to deliver a ... across clinical settings to aid decision-making and ... announced that it earned two of Healthcare ... four of the five categories, ICA was ...
... Consumption and Kidney Cancer , There is no ... kidney cancer, according to a pooled analysis of prospective ... increasing worldwide, but the cause of the increase remains ... to an association between consumption of fat, protein, and ...
... , HARRISBURG, Pa., Nov. 25 In ... School District, the Pennsylvania Department of Health held vaccination clinics ... School on Nov. 19 and Nov. 24. , ... given to approximately 560 parents, students, and staff after an ...
... those with poor glucose control likely to have artery disease ... earlier research, a new study has identified a genetic ... in type 2 diabetes patients with poor sugar glucose (glycemic) ... on a genetic chromosome known as chromosome 9p21 are ...
... to blame, study concludes , , TUESDAY, Nov. 25 (HealthDay News) ... cancer for older women, according to a new study that ... their mammogram habits. , The weight itself is to blame ... who are above their healthy weight have higher levels of ...
Cached Medicine News:Health News:Radiation before surgery improves pancreatic cancer outcomes 2Health News:Radiation before surgery improves pancreatic cancer outcomes 3Health News: Informatics Corporation of America Takes 2008 Healthcare IT Summit by Storm, Winning Two of Five Award Categories 2Health News: Informatics Corporation of America Takes 2008 Healthcare IT Summit by Storm, Winning Two of Five Award Categories 3Health News:Also in the Nov. 25 JNCI 2Health News:Also in the Nov. 25 JNCI 3Health News:Also in the Nov. 25 JNCI 4Health News:Chromosome Linked to Diabetics' Heart Risks 2Health News:Weight Boosts Older Women's Breast Cancer Risk 2Health News:Weight Boosts Older Women's Breast Cancer Risk 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: